"Transplantation, Homologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
Descriptor ID |
D014184
|
MeSH Number(s) |
E04.936.864
|
Concept/Terms |
Transplantation, Homologous- Transplantation, Homologous
- Transplantation, Allogeneic
- Homografting
- Homologous Transplantation
- Allogeneic Transplantation
- Allografting
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Homologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Homologous".
This graph shows the total number of publications written about "Transplantation, Homologous" by people in this website by year, and whether "Transplantation, Homologous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 0 | 2 | 2 |
2014 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 2 | 3 |
2019 | 0 | 2 | 2 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation, Homologous" by people in Profiles.
-
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report. Front Immunol. 2021; 12:727814.
-
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo. Leukemia. 2020 03; 34(3):771-786.
-
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets. Blood Adv. 2019 10 22; 3(20):3143-3156.
-
T-cell receptor-a repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing. Haematologica. 2019 03; 104(3):622-631.
-
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial. Br J Haematol. 2018 10; 183(1):104-109.
-
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 11; 24(11):2337-2343.
-
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial. Br J Haematol. 2018 01; 180(1):82-89.
-
Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy. Blood. 2014 Jul 24; 124(4):628-37.
-
CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT. Immunobiology. 2014 Apr; 219(4):247-60.
-
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. J Clin Oncol. 2013 Jul 20; 31(21):2736-42.